These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Fatal poisoning in a child with pyraphen and norsulfazol]. RAZUMOVSKII IuK Kazan Med Zh; 1962; 1():69. PubMed ID: 14490775 [No Abstract] [Full Text] [Related]
4. Observations on toxicity of aminopyrine and its metabolites in cattle. Banerjee NC; Miller GE; Stowe CM Indian Vet J; 1969 Dec; 46(12):1055-9. PubMed ID: 5382227 [No Abstract] [Full Text] [Related]
5. [Toxicodermia after wofapyrin]. WOLFRAM G Dtsch Gesundheitsw; 1960 Apr; 15():722-9. PubMed ID: 13845735 [No Abstract] [Full Text] [Related]
6. Agranulocytosis due to pyramidon compounds. SARIN LR; KOTIA KC J Indian Med Assoc; 1960 Mar; 34():174-5. PubMed ID: 14441744 [No Abstract] [Full Text] [Related]
7. Agranulocytosis induced by aminopyrine suppositories; recovery following the use of penicillin in a highly allergic individual. URBACH E; GOLDBURGH HL J Am Med Assoc; 1946 Jul; 131():893. PubMed ID: 20988740 [No Abstract] [Full Text] [Related]
8. [Fatal panmyelophthisis due to Rheopyrin]. POGATSA G; SELLYEI M Orv Hetil; 1962 Mar; 103():504-5. PubMed ID: 14487379 [No Abstract] [Full Text] [Related]
9. [Comparative characteristics of the epileptogenic effect and toxicity of concentrated aminopyrine solutions]. Zapadniuk VI Farmakol Toksikol; 1965; 28(1):40-2. PubMed ID: 5845039 [No Abstract] [Full Text] [Related]
10. [Panmyelopathy with fatal outcome caused by aminophenazone]. MICHEELS KH Z Gesamte Inn Med; 1961 Mar; 16():219-21. PubMed ID: 13770212 [No Abstract] [Full Text] [Related]
11. Effect of fasting on the toxicity and serum concentration of aminopyrine in rats. Cornish HH; Morrison AB; Nelson JM Toxicol Appl Pharmacol; 1970 Jul; 17(1):217-22. PubMed ID: 5456637 [No Abstract] [Full Text] [Related]
13. [Occupational dermatitis related to the production of analgin and para-aminosalicylic acid]. NIKONETS IF Vestn Dermatol Venerol; 1960 Apr; 34():60-1. PubMed ID: 14427252 [No Abstract] [Full Text] [Related]
15. [Blood complications of medicinal origin. I. The risks of 2 drugs in current use: pyramidon and chloramphenicol]. LABRAM C Concours Med; 1962 Jul; 84():4299-301. PubMed ID: 14461303 [No Abstract] [Full Text] [Related]
17. [Study of the mechanism of hemolysis in a case of acquired hemolytic anemia caused by pyramidon]. BERNASCONI C; BEDARIDA G; POLLINI G; SARTORI S Haematologica; 1961; 46():697-720. PubMed ID: 13868086 [No Abstract] [Full Text] [Related]
18. [A statistical model for describing chronic toxicity]. Janků I Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):224-5. PubMed ID: 5804252 [No Abstract] [Full Text] [Related]
19. Drug metabolism and fetal toxicity: changes in fetal toxicity of aminopyrine by variation of drug metabolizing enzyme activity in mice. Saito H; Naminohira S; Sakai T; Ueno K; Kitagawa H Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):141-4. PubMed ID: 7313295 [TBL] [Abstract][Full Text] [Related]
20. [Data on the toxicology and hygienic standards of amidopyrine]. Gnezdilova AI; Vasilenko NM; Garmash VM; Baturina TS; Nedbaĭlo EP Gig Tr Prof Zabol; 1979 Aug; (8):46-7. PubMed ID: 488728 [No Abstract] [Full Text] [Related] [Next] [New Search]